Klaus Wuchner

Cilag AG

Klaus has over 20 years’ experience in pharmaceutical R&D with focus on analytical development. Currently, he holds a position as Scientific Director within the global BioTherapeutics Development & Supply organization at Janssen R&D, Schaffhausen, Switzerland. His general areas of responsibility cover strategic, regulatory, and scientific direction for analytical development of large molecule drug products. Klaus established a Center of Excellence in particle testing and container closure integrity testing (CCIT) supporting Janssens’ large molecule and advanced therapeutic medicinal product portfolio. He worked on various products from small molecule APIs to parenteral biopharmaceuticals. He highly appreciates collaboration within multi-industry groups and has extensive consortia experience with leading and participating in workstreams within e.g., EFPIA/MQEG, BioPhorum, and IQ. Prior to joining the pharmaceutical world, Klaus headed the organic residue analysis department in a water laboratory in France. He holds a Ph.D in analytical chemistry of the “Institut National Polytechnique of Toulouse”, France.